LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 24 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,117,000 | -0.2% | 2,800,000 | 0.0% | 0.17% | -4.9% |
| Q3 2017 | $5,126,000 | -35.6% | 2,800,000 | -41.7% | 0.18% | -38.9% |
| Q2 2017 | $7,962,000 | +11.2% | 4,800,000 | 0.0% | 0.30% | +8.8% |
| Q1 2017 | $7,160,000 | +3.0% | 4,800,000 | 0.0% | 0.27% | +5.0% |
| Q4 2016 | $6,952,000 | -1.1% | 4,800,000 | 0.0% | 0.26% | +4.4% |
| Q3 2016 | $7,027,000 | -12.3% | 4,800,000 | 0.0% | 0.25% | -14.1% |
| Q2 2016 | $8,014,000 | +9.5% | 4,800,000 | 0.0% | 0.29% | +21.8% |
| Q1 2016 | $7,316,000 | -1.7% | 4,800,000 | 0.0% | 0.24% | -1.2% |
| Q4 2015 | $7,440,000 | -28.1% | 4,800,000 | -40.0% | 0.24% | -20.7% |
| Q3 2015 | $10,350,000 | – | 8,000,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opera Trading Capital | 5,700,000 | $8,208,000 | 2.47% |
| TFG Asset Management GP Ltd | 8,100,000 | $11,729,000 | 2.33% |
| Mint Tower Capital Management B.V. | 4,500,000 | $6,507,000 | 2.17% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,010,000 | $11,584,000 | 1.75% |
| CQS Cayman LP | 15,000,000 | $21,717,000 | 1.72% |
| LINDEN ADVISORS LP | 21,855,000 | $31,633,000 | 1.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $32,593,000 | 0.92% |
| Myriad Asset Management Ltd. | 9,000,000 | $13,045,000 | 0.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,000,000 | $36,172,000 | 0.64% |
| CSS LLC/IL | 5,500,000 | $7,955,000 | 0.43% |